Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-02-20 @ 6:21 PM
Study NCT ID:
NCT02282059
Status:
COMPLETED
Last Update Posted:
2024-06-20
First Post:
2014-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-15
First Submit QC Date:
None
Study First Post Date:
2014-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-11-22
Results First Submit QC Date:
None
Results First Post Date:
2024-06-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-03
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL